Stryker Corporation (SYK)

SYK (NYSE:Health Services)
$78.78
pos +0.00
+0.00%
Today's Range: 78.49 - 79.45 | SYK Avg Daily Volume: 1,705,900
Last Update: 04/17/14 - 4:03 PM EDT
Volume: 0
YTD Performance: 4.84%
Open: $0.00
Previous Close: $79.05
52 Week Range: $63.35 - $84.85
Oustanding Shares: 377,870,936
Market Cap: 29,794,591,825
6-Month Chart
TheStreet Ratings Grade for SYK
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 12 12 12 12
Moderate Buy 1 1 1 1
Hold 10 9 9 10
Moderate Sell 0 0 0 0
Strong Sell 0 1 1 1
Mean Rec. 1.89 1.98 1.98 2.02
Latest Dividend: 0.30
Latest Dividend Yield: 1.50%
Dividend Ex-Date: 03/27/14
Price Earnings Ratio: 31.00
Price Earnings Comparisons:
SYK Sector Avg. S&P 500
31.00 29.90 29.08
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
0.74% 22.33% 29.79%
GROWTH 12 Mo 3 Yr CAGR
Revenue 4.20 0.23 0.07
Net Income -22.50 -0.21 -0.07
EPS -22.30 -0.17 -0.06
Earnings for SYK:
EBITDA 1.61B
Revenue 9.02B
Average Earnings Estimates
Qtr (03/14) Qtr (06/14) FY (12/14) FY (12/15)
Average Estimate $1.08 $1.13 $4.83 $5.29
Number of Analysts 17 16 20 17
High Estimate $1.14 $1.18 $4.87 $5.37
Low Estimate $1.00 $1.09 $4.77 $5.10
Prior Year $1.03 $1.00 $4.23 $4.83
Growth Rate (Year over Year) 5.31% 13.44% 14.22% 9.45%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

David Katz

 | Mar 28, 2014 | 7:40 AM EDT

Positive developments and an attractive entry point make the stock a table-pounding buy.

bullishStryker estimates, target raised at Goldman

Feb 18, 2014 | 8:34 AM EST

Shares of SYK now seen reaching $86, according to Goldman Sachs. Estimates also increased, given better working capital use and higher realized margins. Buy rating. 

updateLeerink Healthcare Conf.

Feb 13, 2014 | 7:31 AM EST

Leerink Swann Global Healthcare Conference (Day 2 of 2) - 02/12/14 - 02/13/14 New York, NY

By

David Katz

 | Feb 7, 2014 | 10:35 AM EST

They should improve shareholder value in coming months.

By

David Katz

 | Dec 10, 2013 | 1:00 PM EST

The medical technology firm's acquisitions are starting to pay off. 

By

Timothy Collins

 | Oct 18, 2013 | 9:50 AM EDT
Earnings reactions are lifting the entire market. 

bullishStryker upgraded at Credit Suisse

Sep 6, 2013 | 8:25 AM EDT

SYK was upgraded from Neutral to Outperform, Credit Suisse said. $77 price target. Valuation call, as the stock has pulled back 14% and the company generates strong free cash flow. 

bearishStryker downgraded at Wunderlich

Jul 19, 2013 | 7:06 AM EDT

SYK was downgraded from Buy to Hold, Wunderlich said. $71 price target. Company lacks near-term catalysts. 

By

Jim Cramer

 | Mar 4, 2013 | 6:00 AM EST

Safety stocks aren’t every going to be crushed, but could certainly stumble.

bearishStryker downgraded at Credit Suisse

Feb 7, 2013 | 7:55 AM EST

SYK was downgraded from Outperform to Neutral, Credit Suisse said. Valuation call, based on a $67 price target. 

The new Fed Chief said this at a recent meeting of the Economic Club of NY ... "We have in...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.